Regeneron Pharmaceuticals (REGN) EBITDA (2009 - 2026)
Regeneron Pharmaceuticals' EBITDA was $1.42 billion in Q2 2026, up 16.7% from $1.21 billion a year earlier and up 85.0% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EBITDA (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regeneron Pharmaceuticals' EBITDA was $4.37 billion through Jun 30, 2026, up 0.5% year-over-year; for FY2025, it came in at $4.12 billion, down 7.9% from FY2024.
- EBITDA shows a five-year compound annual growth rate of 1.6% (FY2020 to FY2025).
- In earlier years, EBITDA was $4.47 billion in FY2024 (+0.1%), $4.47 billion in FY2023 (-12.1%), $5.08 billion in FY2022 (-45.0%) and $9.23 billion in FY2021 (+142.2%).
- The Q2 2026 figure marks the highest quarterly EBITDA since Q4 2021.
- Compared with a year earlier, EBITDA was higher in five of the last eight quarters, with an average decline of 0.1%.
- The best year-over-year quarter for EBITDA over five years was Q4 2021 (growth of 120.9%); the worst was Q2 2022 (a decline of 65.4%).
- Per Business Quant data, REGN's EBITDA in the three quarters before Q2 2026 was $766.1 million (Q1 2026), $1.02 billion (Q4 2025) and $1.16 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Regeneron Pharmaceuticals | 91.70 Bn | 57.05 Bn | 4.54 Bn | 2.17 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 2.17 Bn |
| Jun 30, 2026 | 1.42 Bn |
| Mar 31, 2026 | 766.10 Mn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 1.16 Bn |
| Jun 30, 2025 | 1.21 Bn |
| Mar 31, 2025 | 718.60 Mn |
| Dec 31, 2024 | 1.12 Bn |
| Sep 30, 2024 | 1.30 Bn |
| Jun 30, 2024 | 1.19 Bn |
| Mar 31, 2024 | 865.50 Mn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.22 Bn |
| Jun 30, 2023 | 1.12 Bn |
| Mar 31, 2023 | 1.05 Bn |
| Dec 31, 2022 | 1.25 Bn |
| Sep 30, 2022 | 1.32 Bn |
| Jun 30, 2022 | 1.18 Bn |
| Mar 31, 2022 | 1.33 Bn |
| Dec 31, 2021 | 2.71 Bn |
API Access
Regeneron Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();